The Possible Practical Implication of High CRP Levels in PCOS

doi:10.1177/1179558119861936

Editorial

. 2019 Jul 22:13:1179558119861936.

doi: 10.1177/1179558119861936. eCollection 2019.

The Possible Practical Implication of High CRP Levels in PCOS

Zeev Blumenfeld¹

Affiliations

PMID: 31384138
PMCID: PMC6647201
DOI: 10.1177/1179558119861936

Editorial

The Possible Practical Implication of High CRP Levels in PCOS

Zeev Blumenfeld. Clin Med Insights Reprod Health. 2019.

. 2019 Jul 22:13:1179558119861936.

doi: 10.1177/1179558119861936. eCollection 2019.

Author

Zeev Blumenfeld¹

Affiliation

¹ Reproductive Endocrinology, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

PMID: 31384138
PMCID: PMC6647201
DOI: 10.1177/1179558119861936

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

**Figure 1.**
Significantly higher prevalence of high C-reactive protein level (>5 mg/L) in polycystic ovary syndrome (PCOS) patients compared with age- and body mass index–adjusted controls.

See this image and copyright information in PMC

Cited by

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome.
Shan H, Luo R, Guo X, Li R, Ye Z, Peng T, Liu F, Yang Z. Shan H, et al. Front Pharmacol. 2022 Jul 25;13:904942. doi: 10.3389/fphar.2022.904942. eCollection 2022. Front Pharmacol. 2022. PMID: 35959444 Free PMC article. Review.
The Effect of Ageing on Clinical, Hormonal and Sonographic Features Associated with PCOS-A Long-Term Follow-Up Study.
Jacewicz-Święcka M, Wołczyński S, Kowalska I. Jacewicz-Święcka M, et al. J Clin Med. 2021 May 13;10(10):2101. doi: 10.3390/jcm10102101. J Clin Med. 2021. PMID: 34068234 Free PMC article.
Hypothalamic-Ovarian axis and Adiposity Relationship in Polycystic Ovary Syndrome: Physiopathology and Therapeutic Options for the Management of Metabolic and Inflammatory Aspects.
Lonardo MS, Cacciapuoti N, Guida B, Di Lorenzo M, Chiurazzi M, Damiano S, Menale C. Lonardo MS, et al. Curr Obes Rep. 2024 Mar;13(1):51-70. doi: 10.1007/s13679-023-00531-2. Epub 2024 Jan 3. Curr Obes Rep. 2024. PMID: 38172476 Free PMC article. Review.
Green cardamom plus low-calorie diet can decrease the expression of inflammatory genes among obese women with polycystic ovary syndrome: a double-blind randomized clinical trial.
Cheshmeh S, Ghayyem M, Khamooshi F, Heidarzadeh-Esfahani N, Rahmani N, Hojati N, Mosaieby E, Moradi S, Pasdar Y. Cheshmeh S, et al. Eat Weight Disord. 2022 Mar;27(2):821-830. doi: 10.1007/s40519-021-01223-3. Epub 2021 May 31. Eat Weight Disord. 2022. PMID: 34057705 Free PMC article. Clinical Trial.
Plumbagin rescues the granulosa cell's pyroptosis by reducing WTAP-mediated N6-methylation in polycystic ovary syndrome.
Cai Z, He S, Liu R, Zhou L, Zhao L. Cai Z, et al. J Ovarian Res. 2022 Dec 3;15(1):126. doi: 10.1186/s13048-022-01058-1. J Ovarian Res. 2022. PMID: 36463191 Free PMC article.

See all "Cited by" articles

References

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078–3082. doi:10.1210/jcem.83.9.5090. - DOI - PubMed
1. Copp T, Jansen J, Doust J, Mol BW, Dokras A, McCaffery K. Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome? BMJ. 2017;358:j3694. - PubMed
1. Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011;9:39. doi:10.1186/1477-7827-9-39. - DOI - PMC - PubMed
1. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544–551. doi:10.1093/humrep/dep399. - DOI - PubMed
1. Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067–3073. doi:10.1093/humrep/des232. - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

[1] Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078–3082. doi:10.1210/jcem.83.9.5090. - DOI - PubMed

[2] Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078–3082. doi:10.1210/jcem.83.9.5090. - DOI - PubMed

[3] Copp T, Jansen J, Doust J, Mol BW, Dokras A, McCaffery K. Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome? BMJ. 2017;358:j3694. - PubMed

[4] Copp T, Jansen J, Doust J, Mol BW, Dokras A, McCaffery K. Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome? BMJ. 2017;358:j3694. - PubMed

[5] Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011;9:39. doi:10.1186/1477-7827-9-39. - DOI - PMC - PubMed

[6] Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011;9:39. doi:10.1186/1477-7827-9-39. - DOI - PMC - PubMed

[7] March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544–551. doi:10.1093/humrep/dep399. - DOI - PubMed

[8] March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544–551. doi:10.1093/humrep/dep399. - DOI - PubMed

[9] Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067–3073. doi:10.1093/humrep/des232. - DOI - PubMed

[10] Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067–3073. doi:10.1093/humrep/des232. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The Possible Practical Implication of High CRP Levels in PCOS

Affiliation

The Possible Practical Implication of High CRP Levels in PCOS

Author

Affiliation

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous